Successful use of a selective serotonin reuptake inhibitor in a patient with multiple chemical sensitivities

被引：8
|
作者：
Andine, P
Ronnback, L
Jarvholm, B
机构：
[1] SAHLGRENS UNIV HOSP, INST CLIN NEUROSCI, DEPT NEUROL, S-41345 GOTHENBURG, SWEDEN
[2] NORRLAND UNIV HOSP, DEPT OCCUPAT MED, UMEA, SWEDEN
来源：
ACTA PSYCHIATRICA SCANDINAVICA | 1997年 / 96卷 / 01期
关键词：
citalopram; depression; multiple chemical sensitivities;
D O I：
10.1111/j.1600-0447.1997.tb09910.x
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
A 53-year-old man with multiple chemical sensitivities (MCS) received the selective serotonin reuptake inhibitor (SSRI) citalopram for treatment of depression. The treatment was successful and, in parallel to the remission of the depressive symptoms, all MCS symptoms vanished. This suggests that a subgroup of MCS patients may have an atypical depression, that they should be psychiatrically evaluated, and that antidepressive pharmacological treatment may be considered in cases of MCS.
引用
收藏
页码：82 / 83
页数：2
相关论文
共 50 条
  • [11] Upper gastrointestinal bleeding in a patient with depression receiving selective serotonin reuptake inhibitor therapy
    Kumar, Deepak
    Saaraswat, Tanuj
    Sengupta, S. N.
    Mehrotra, Saurabh
    INDIAN JOURNAL OF PHARMACOLOGY, 2009, 41 (01) : 51 - 53
  • [12] EFFECTIVE TREATMENT OF POSTSTROKE DEPRESSION WITH THE SELECTIVE SEROTONIN REUPTAKE INHIBITOR CITALOPRAM
    ANDERSEN, G
    VESTERGAARD, K
    LAURITZEN, L
    STROKE, 1994, 25 (06) : 1099 - 1104
  • [13] Cardiac Toxicity in Selective Serotonin Reuptake Inhibitor Users
    Lusetti, Monia
    Licata, Manuela
    Silingardi, Enrico
    Bonetti, Luca Reggiani
    Palmiere, Cristian
    AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY, 2015, 36 (04) : 293 - 297
  • [14] Selective serotonin reuptake inhibitor-induced akathisia
    Koliscak, Lindsey P.
    Makela, Eugene H.
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2009, 49 (02) : E28 - E38
  • [15] Selective Serotonin Reuptake Inhibitor Use and Risk of Arrhythmia: A Nationwide, Population-Based Cohort Study
    Lin, Yi-Ting
    Lu, Tsui-Shan
    Hansen, Richard A.
    Wang, Chi-Chuan
    CLINICAL THERAPEUTICS, 2019, 41 (06) : 1128 - 1138
  • [16] Prestroke selective serotonin reuptake inhibitor use and functional outcomes after ischaemic stroke
    Etherton, Mark R.
    Siddiqui, Khawja A.
    Schwamm, Lee H.
    STROKE AND VASCULAR NEUROLOGY, 2018, 3 (01) : 9 - 16
  • [17] Use of selective serotonin reuptake inhibitor medications for the treatment of child and adolescent mental illness
    Korczak, Daphne J.
    PAEDIATRICS & CHILD HEALTH, 2013, 18 (09) : 487 - 491
  • [18] Selective serotonin reuptake inhibitor use and bone mineral density in women with a history of depression
    Williams, Lana J.
    Henry, Margaret J.
    Berk, Michael
    Dodd, Seetal
    Jacka, Felice N.
    Kotowicz, Mark A.
    Nicholson, Geoffrey C.
    Pasco, Julie A.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2008, 23 (02) : 84 - 87
  • [19] Selective Serotonin Reuptake Inhibitor Use and Hip Fracture Risk Among Patients on Hemodialysis
    Vangala, Chandan
    Niu, Jingbo
    Montez-Rath, Maria E.
    Yan, Jingyin
    Navaneethan, Sankar D.
    Winkelmayer, Wolfgang C.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2020, 75 (03) : 351 - 360
  • [20] Economic Impact of Therapeutic Substitution of a Brand Selective Serotonin Reuptake Inhibitor with an Alternative Generic Selective Serotonin Reuptake Inhibitor in Patients with Major Depressive Disorder
    Wu, Eric Q.
    Yu, Andrew P.
    Lauzon, Veronique
    Ramakrishnan, Karthik
    Marynchenko, Maryna
    Ben-Hamadi, Rym
    Blum, Steven
    Erder, M. Haim
    ANNALS OF PHARMACOTHERAPY, 2011, 45 (04) : 441 - 451
12345